Cargando…

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by the loss of upper and lower motor neurons (MNs) in the cerebral cortex, brainstem and spinal cord, with consequent weakness, atrophy and the progressive paralysis of all muscles. There is currently no medical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proaño, Belén, Casani-Cubel, Julia, Benlloch, María, Rodriguez-Mateos, Ana, Navarro-Illana, Esther, Lajara-Romance, Jose María, de la Rubia Ortí, Jose Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495995/ https://www.ncbi.nlm.nih.gov/pubmed/36140184 http://dx.doi.org/10.3390/biomedicines10092084

Ejemplares similares

The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview
por: Casani-Cubel, Julia, et al.
Publicado: (2021)

Lipid Profile in Multiple Sclerosis: Functional Capacity and Therapeutic Potential of Its Regulation after Intervention with Epigallocatechin Gallate and Coconut Oil
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2023)

Intake of Vitamin D in Patients with Multiple Sclerosis in the Valencian Region and Its Possible Relationship with the Pathogenesis of the Disease
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
por: Caplliure-Llopis, Jordi, et al.
Publicado: (2020)

Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2023)

Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
por: Carrera-Juliá, Sandra, et al.
Publicado: (2020)

Bone Quality in Patients with Parkinson’s Disease Determined by Quantitative Ultrasound (QUS) of the Calcaneus: Influence of Sex Differences
por: Caplliure-Llopis, Jordi, et al.
Publicado: (2022)

Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review
por: Caplliure‐Llopis, Jordi, et al.
Publicado: (2019)

Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study
por: Carrera-Juliá, Sandra, et al.
Publicado: (2023)

Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2023)

Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis
por: Cuerda-Ballester, María, et al.
Publicado: (2023)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Muscular Response in ALS Patients during Maximal Bilateral Isometric Work of the Biceps Brachii until Fatigue
por: Alarcón-Jimenez, Jorge, et al.
Publicado: (2022)

Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019)

Sensory Involvement in Amyotrophic Lateral Sclerosis
por: Rubio, Miguel A., et al.
Publicado: (2022)

Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2020)

Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study
por: Benlloch, María, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Amyotrophic Lateral Sclerosis: From Mechanisms to Current, Emerging, and Alternative Therapeutics
por: Kioutchoukova, Ivelina P, et al.
Publicado: (2023)

The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients
por: Platero, Jose Luis, et al.
Publicado: (2021)

Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients
por: Benlloch, María, et al.
Publicado: (2019)

Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study
por: de la Rubia Ortí, Jose Enrique, et al.
Publicado: (2021)

The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
por: Loeffler, Jean‐Philippe, et al.
Publicado: (2016)

Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
por: Kim, Sungha, et al.
Publicado: (2019)

Complementary and alternative medicine for treating amyotrophic lateral sclerosis: a narrative review
por: Cai, Mudan, et al.
Publicado: (2019)

Digital Alternative Communication for Individuals with Amyotrophic Lateral Sclerosis: What We Have
por: Fernandes, Felipe, et al.
Publicado: (2023)

Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”
por: Benlloch, María, et al.
Publicado: (2019)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
por: Robelin, Laura, et al.
Publicado: (2014)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015)

Diverse roles of FUS in Amyotrophic Lateral Sclerosis
por: Carri, Maria Teresa, et al.
Publicado: (2015)

Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Alessenko, Alisa V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_084lvc6il9v1fpqab48bg5r0b8